These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33812776)

  • 1. Interrogating immune cells and cancer with CRISPR-Cas9.
    Buquicchio FA; Satpathy AT
    Trends Immunol; 2021 May; 42(5):432-446. PubMed ID: 33812776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR technology for immuno-oncology applications.
    Wang J; Balan V; Marincola F
    Methods Enzymol; 2020; 635():251-266. PubMed ID: 32122549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immunology CRISPR screening: present, past, and future.
    Dong MB; Tang K; Zhou X; Zhou JJ; Chen S
    Trends Cancer; 2022 Mar; 8(3):210-225. PubMed ID: 34920978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
    Cheng X; Fan S; Wen C; Du X
    Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
    Potts MA; McDonald JA; Sutherland KD; Herold MJ
    Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 for the Clinician: Current uses of gene editing and applications for new therapeutics in oncology.
    Boland J; Nedelcu E
    Perm J; 2020 Dec; 24():1-3. PubMed ID: 33482972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas system: a powerful tool for genome engineering.
    Liu L; Fan XD
    Plant Mol Biol; 2014 Jun; 85(3):209-18. PubMed ID: 24639266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases.
    Singh DD; Hawkins RD; Lahesmaa R; Tripathi SK
    Semin Cell Dev Biol; 2019 Dec; 96():32-43. PubMed ID: 31112800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in CRISPR/Cas9 technology-Focusing on cancer therapeutics and beyond.
    Mirza Z; Karim S
    Semin Cell Dev Biol; 2019 Dec; 96():13-21. PubMed ID: 31150758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
    Li GL; Yang SX; Wu ZF; Zhang XW
    Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Cas System: An efficient tool for cancer modelling.
    Akhtar M; Jamal T; Khan M; Khan SR; Haider S; Jalil F
    J Pak Med Assoc; 2021 Feb; 71(2(B)):718-724. PubMed ID: 33941966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CRISPR-Cas in advancing precision periodontics.
    Barbour A; Glogauer J; Grinfeld L; Ostadsharif Memar R; Fine N; Tenenbaum H; Glogauer M
    J Periodontal Res; 2021 Jun; 56(3):454-461. PubMed ID: 33452819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.